The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Diversion of aspartate in ASS1-deficient tumours fosters de novo pyrimidine synthesis
Open accessAbstract
Cancer cells hijack and remodel existing metabolic pathways for their benefit. Argininosuccinate synthase (ASS1) is a urea cycle enzyme that is essential in the conversion of nitrogen from ammonia and aspartate to urea. A decrease in nitrogen flux through ASS1 in the liver causes the urea cycle disorder citrullinaemia. In contrast to the well-studied consequences of loss of ASS1 activity on ureagenesis, the purpose of its somatic silencing in multiple cancers is largely unknown. Here we show that decreased activity of ASS1 in cancers supports proliferation by facilitating pyrimidine synthesis via CAD (carbamoyl-phosphate synthase 2, aspartate transcarbamylase, and dihydroorotase complex) activation. Our studies were initiated by delineating the consequences of loss of ASS1 activity in humans with two types of citrullinaemia. We find that in citrullinaemia type I (CTLN I), which is caused by deficiency of ASS1, there is increased pyrimidine synthesis and proliferation compared with citrullinaemia type II (CTLN II), in which there is decreased substrate availability for ASS1 caused by deficiency of the aspartate transporter citrin. Building on these results, we demonstrate that ASS1 deficiency in cancer increases cytosolic aspartate levels, which increases CAD activation by upregulating its substrate availability and by increasing its phosphorylation by S6K1 through the mammalian target of rapamycin (mTOR) pathway. Decreasing CAD activity by blocking citrin, the mTOR signalling, or pyrimidine synthesis decreases proliferation and thus may serve as a therapeutic strategy in multiple cancers where ASS1 is downregulated. Our results demonstrate that ASS1 downregulation is a novel mechanism supporting cancerous proliferation, and they provide a metabolic link between the urea cycle enzymes and pyrimidine synthesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Genetic or epigenetic silencing of ASS1 expression provides an advantage to tumor cells by allowing them to preserve cellular aspartate (Rabinovich et al., 2015), a poorly transported nutrient that can be a critical output of the TCA cycle to support de novo nucleotide synthesis and cell proliferation (Birsoy et al., 2015; Sullivan et al., 2015).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Rabinovich et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global reconstruction of the human metabolic network based on genomic and bibliomic data
Duarte, N. C., Becker, S. A., Jamshidi, N., Thiele, I., Mo, M. L., Vo, T. D., Srivas, R., & Palsson, B. Ø. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610772104 · Cited by 1,374
Metabolic Flux Balancing: Basic Concepts, Scientific and Practical Use
Varma, A., & Palsson, B. Ø. (1994) · Nature Biotechnology · doi:10.1038/nbt1094-994 · Cited by 945
Stimulation of de novo pyrimidine synthesis by growth signaling through mTOR and S6K1
Ben-Sahra, I., Howell, J. J., Asara, J. M., & Manning, B. D. (2013) · Science · doi:10.1126/science.1228792 · Cited by 739
Quantitative Phosphoproteomics Reveal mTORC1 Activates de Novo Pyrimidine Synthesis
Robitaille, A. M., Christen, S., Shimobayashi, M., Cornu, M., Fava, L. L., Moes, S., Prescianotto-Baschong, C., Sauer, U., Jenoe, P., & Hall, M. N. (2013) · Science · doi:10.1126/science.1228771 · Cited by 525
Recent advances in arginine metabolism: roles and regulation of the arginases
Morris Jr, S. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00278.x · Cited by 485
Predicting selective drug targets in cancer through metabolic networks
Folger, O., Jerby‐Arnon, L., Frezza, C., Gottlieb, E., Ruppin, E., & Shlomi, T. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.35 · Cited by 480
Self-citationArginine deprivation and argininosuccinate synthetase expression in the treatment of cancer
Delage, B., Fennell, D. A., Nicholson, L., McNeish, I., Lemoine, N. R., Crook, T., & Szlosarek, P. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25202 · Cited by 441
Single-molecule transcript counting of stem-cell markers in the mouse intestine
Itzkovitz, S., Lyubimova, A., Blat, I. C., Maynard, M. A., van Es, J. H., Lees, J. A., Jacks, T., Clevers, H. C., & van Oudenaarden, A. (2011) · Nature Cell Biology · doi:10.1038/ncb2384 · Cited by 352
Self-citationLee, J. K., Havaleshko, D. M., Cho, H., Weinstein, J. N., Kaldjian, E. P., Karpovich, J. F., Grimshaw, A. S., & Theodorescu, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610292104 · Cited by 311
Integrative Genome Comparison of Primary and Metastatic Melanomas
Kabbarah, O., Nogueira, C., Feng, B., Nazarian, R. M., Bosenberg, M., Wu, M., Scott, K. L., Kwong, L. N., Xiao, Y., Cordon‐Cardo, C., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010770 · Cited by 262
Flagged first, then by citations
Research works printed but not linked: 1
- Kobayashi, K., Saheki, T. & Song, Y. Z. Citrin deficiency. GeneReviews http://www.ncbi.nlm.nih.gov/books/NBK1181/ (2005)
Cited by
Sorted by citations
Items 101–200 of 382
Serum Metabolomics Study of Papillary Thyroid Carcinoma Based on HPLC-Q-TOF-MS/MS
Du, Y., Fan, P., Zou, L., Jiang, Y., Gu, X., Yu, J., & Zhang, C. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.593510 · Cited by 66
Wu, T., Luo, G., Lian, Q., Sui, C., Tang, J. P., Zhu, Y., Zheng, B. J., Li, Z., Zhang, Y., Zhang, Y., et al. (2021) · Hepatology · doi:10.1002/hep.32088 · Cited by 65
Polyamine Homeostasis in Development and Disease
Nakanishi, S., & Cleveland, J. L. (2021) · Medical Sciences · doi:10.3390/medsci9020028 · Cited by 68
Beyond glucose: alternative sources of energy in glioblastoma
Caniglia, J. L., Jalasutram, A., Asuthkar, S., Sahagun, J., Park, S. J., Ravindra, A., Tsung, A. J., Guda, M. R., & Velpula, K. K. (2020) · Theranostics · doi:10.7150/thno.53506 · Cited by 61
Zhu, Z., Cao, C., Zhang, D., Zhang, Z., Liu, L., Wu, D., & Sun, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04596-0 · Cited by 61
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma
Szlosarek, P. W., Creelan, B., Sarkodie, T., Nolan, L., Taylor, P. D., Olevsky, O. M., Grosso, F., Cortinovis, D. L., Chitnis, M. M., Roy, A., et al. (2024) · JAMA Oncology · doi:10.1001/jamaoncol.2023.6789 · Cited by 61
Du, S., Wang, Y., Alatrash, N., Weatherly, C. A., Roy, D., MacDonnell, F. M., & Armstrong, D. W. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.10.047 · Cited by 64
Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
Jahani, M., Noroznezhad, F., & Mansouri, K. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.109 · Cited by 61
Exploiting metabolic vulnerabilities for personalized therapy in acute myeloid leukemia
Stuani, L., Sabatier, M., & Sarry, J. (2019) · BMC Biology · doi:10.1186/s12915-019-0670-4 · Cited by 66
Locke, M., Ghazaly, E. A., Freitas, M. O., Mitsinga, M., Lattanzio, L., Nigro, C. L., Nagano, A., Wang, J., Chelala, C., Szlosarek, P. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.097 · Cited by 57
Infantino, V., Dituri, F., Convertini, P., Santarsiero, A., Palmieri, F., Todisco, S., Mancarella, S., Giannelli, G., & Iacobazzi, V. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.10.018 · Cited by 56
Sciacovelli, M., Dugourd, A. J. F., Valcárcel-Jiménez, L., Yang, M. H., Nikitopoulou, E., Costa, A. S. H., Tronci, L., Caraffini, V., Rodrigues, P., Schmidt, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35036-4 · Cited by 62
Self-citationThe interplay between metabolic remodeling and immune regulation in glioblastoma
Kesarwani, P., Kant, S., Prabhu, A. H., & Chinnaiyan, P. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox079 · Cited by 56
The arginine metabolism and its deprivation in cancer therapy
Feng, T., Xie, F., Lyu, Y., Yu, P., Chen, B., Yu, J., Zhang, G., To, K. F., Tsang, C. M., & Kang, W. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217680 · Cited by 54
Díez‐Fernández, C., Rüfenacht, V., & Häberle, J. (2017) · Human Mutation · doi:10.1002/humu.23184 · Cited by 53
Barbato, A., Scandura, G., Puglisi, F., Cambria, D., Spina, E. L., Palumbo, G. A., Lazzarino, G., Tibullo, D., Raimondo, F. D., Giallongo, C., et al. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.604143 · Cited by 53
Hsu, S.-C., Chen, C., Cheng, M., Chu, C.-Y., Changou, C. A., Yu, Y., Yeh, S.-D., Kuo, T.-C., Kuo, C.-C., Chuu, C., et al. (2021) · Theranostics · doi:10.7150/thno.54695 · Cited by 51
Acidosis orchestrates adaptations of energy metabolism in tumors
Groessl, S., Kalis, R., Snaebjornsson, M. T., Wambach, L., Haider, J., Andersch, F., Schulze, A., Palm, W., & Zuber, J. A. (2025) · Science · doi:10.1126/science.adp7603 · Cited by 58
Arginine reprogramming in ADPKD results in arginine-dependent cystogenesis
Trott, J. F., Hwang, V. J., Ishimaru, T., Chmiel, K. J., Zhou, J. X., Shim, K., Stewart, B. J., Mahjoub, M. R., Jen, K., Barupal, D. K., et al. (2018) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00025.2018 · Cited by 52
Argininosuccinate Synthase 1 is a Metabolic Regulator of Colorectal Cancer Pathogenicity
Bateman, L. A., Ku, W.-M., Heslin, M. J., Contreras, C. M., Skibola, C. F., & Nomura, D. K. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.6b01158 · Cited by 50
The emerging relationship between metabolism and DNA repair
Cucchi, D., Gibson, A., & Martin, S. A. (2021) · Cell Cycle · doi:10.1080/15384101.2021.1912889 · Cited by 55
Analysis of Gene Expression in 3D Spheroids Highlights a Survival Role for ASS1 in Mesothelioma
Barbone, D., Van Dam, L., Follo, C., Jithesh, P. V., Zhang, S.-D., Richards, W. G., Bueno, R., Fennell, D. A., & Broaddus, V. C. (2016) · PLOS ONE · doi:10.1371/journal.pone.0150044 · Cited by 48
Helenius, I. T., Madala, H. R., & Yeh, J.-R. J. (2021) · Biomolecules · doi:10.3390/biom11111666 · Cited by 43
Moretton, A., Kourtis, S., Zapater, A. G., Calabrò, C., Espinar, L., Fontaine, F., Darai, E., Abad, E., Block, S., Pascual‐Reguant, L., et al. (2023) · Molecular Systems Biology · doi:10.15252/msb.202211267 · Cited by 46
Role of ammonia in NAFLD: An unusual suspect
Thomsen, K. L., Eriksen, P. L., Kerbert, A. J. C., Chiara, F. D., Jalan, R., & Vilstrup, H. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100780 · Cited by 58
Research into cancer metabolomics: Towards a clinical metamorphosis
Olivares, O., Däbritz, J. H. M., King, A., Gottlieb, E., & Halsey, C. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.09.008 · Cited by 45
Harding, J. J., Do, R. K., Dika, I. E., Hollywood, E. M., Uhlitskykh, K., Valentino, E., Wan, P., Hamilton, C. R., Feng, X., Johnston, A. L., et al. (2018) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-018-3635-3 · Cited by 44
Bednarz-Misa, I. S., Fleszar, M. G., Fortuna, P., Lewandowski, Ł., Mierzchała-Pasierb, M., Diakowska, D., & Krzystek‐Korpacka, M. (2021) · Biomolecules · doi:10.3390/biom11081086 · Cited by 45
Werner, A., Pieh, D., Echchannaoui, H., Rupp, J., Rajalingam, K., Theobald, M., Closs, E. I., & Munder, M. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01268 · Cited by 44
ASS1 and ASL suppress growth in clear cell renal cell carcinoma via altered nitrogen metabolism
Khare, S., Kim, L. C., Lobel, G. P., Doulias, P., Ischiropoulos, H., Nissim, I., Keith, B., & Simon, M. C. (2021) · Cancer & Metabolism · doi:10.1186/s40170-021-00271-8 · Cited by 43
Fan, S., Wang, W., Che, W., Xu, Y., Jin, C., Dong, L., & Xia, Q. (2025) · Metabolites · doi:10.3390/metabo15030201 · Cited by 43
Nouwen, L. V., & Everts, B. (2020) · Cells · doi:10.3390/cells9010161 · Cited by 43
Small Molecule Inhibition of CPS1 Activity through an Allosteric Pocket
Yao, S., Nguyen, T.-V., Rolfe, A., Agrawal, A. A., Ke, J., Peng, S., Colombo, F., Yu, S., Bouchard, P., Wu, J., et al. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.01.009 · Cited by 42
Proteomic analysis of lung cancer cells reveals a critical role of BCAT1 in cancer cell metastasis
Mao, L., Jin, C., Lu, X. M., Yang, C., Ding, Y. G., Wang, M., Zhang, Y., Tian, Y., Li, X., Fu, Y., et al. (2021) · Theranostics · doi:10.7150/thno.61731 · Cited by 42
Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice
Kishimoto, S., Brender, J. R., Crooks, D. R., Matsumoto, S., Seki, T., Oshima, N., Merkle, H., Lin, P., Reed, G., Chen, A. P., et al. (2019) · eLife · doi:10.7554/elife.46312 · Cited by 41
“Further, PDAC tumors usually have alterations in the activity in the urea cycle to support pyrimidine and amino acid synthesis (Rabinovich et al., 2015; Liu et al., 2017b) and often display a Warburg phenotype of increased glycolysis followed by diversion to lactate (Anderson et al., 2017).”
SARS-CoV-2 couples evasion of inflammatory response to activated nucleotide synthesis
Qin, C., Rao, Y., Yuan, H., Wang, T., Zhao, J., Espinosa, B., Liu, Y., Zhang, S. J., Savas, A. C., Liu, Q., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122897119 · Cited by 41
Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC
Pham‐Danis, C., Gehrke, S. A., Danis, E. P., Rozhok, A. I., Daniels, M. W., Gao, D., Collins, C., Paola, J. T. D., D’Alessandro, A., & DeGregori, J. V. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-1068 · Cited by 41
Kim, S. S., Xu, S., Cui, J., Poddar, S., Le, T. M., Hayrapetyan, H., Li, L., Wu, N., Moore, A. M., Zhou, L., et al. (2019) · Theranostics · doi:10.7150/thno.40195 · Cited by 40
Mitochondrial Redox Metabolism: The Epicenter of Metabolism during Cancer Progression
Choudhury, F. K. (2021) · Antioxidants · doi:10.3390/antiox10111838 · Cited by 44
Hsu, D. J., Gao, J., Yamaguchi, N., Pinzaru, A. M., Wu, Q., Nandan, M. O., Liberti, M. V., Heissel, S., Alwaseem, H., Tavazoie, S., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade9120 · Cited by 39
Wang, K., Sun, Y., Guo, C., Liu, T., Fei, X., & Chang, C. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1330-x · Cited by 39
Singh, P. K., Deorukhkar, A., Venkatesulu, B. P., Li, X., Tailor, R. C., Bomalaski, J. S., & Krishnan, S. (2019) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0708 · Cited by 39
Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenograftsPreprint
Quinn, J. J., Jones, M. G., Okimoto, R. A., Nanjo, S., Chan, M. M., Yosef, N., Bivona, T. G., & Weissman, J. S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.16.045245 · Cited by 38
Gai, X., Liu, Y., Lan, X., Chen, L., Yuan, T., Xu, J., Li, Y., Zheng, Y., Yan, Y., Yang, L., et al. (2024) · Cancer Research · doi:10.1158/0008-5472.can-23-2095 · Cited by 40
ASS1 metabolically contributes to the nuclear and cytosolic p53-mediated DNA damage response
Lim, L. Q. J., Adler, L. N., Hajaj, E., Soria, L. R., Perry, R. B., Darzi, N., Brody, R., Furth, N., Lichtenstein, M., Bab-Dinitz, E., et al. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01060-5 · Cited by 38
Self-citationArgininosuccinate synthase 1, arginine deprivation therapy and cancer management
Sun, N., & Zhao, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.935553 · Cited by 36
A metabolic link between the urea cycle and cancer cell proliferation
Nagamani, S. C. S., & Erez, A. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2015.1127314 · Cited by 36
Self-citationHall, P. E., Ready, N., Johnston, A. L., Bomalaski, J. S., Venhaus, R. R., Sheaff, M. T., Krug, L. M., & Szlosarek, P. W. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.07.012 · Cited by 35
Agnello, G., Alters, S. E., & Rowlinson, S. W. (2019) · Translational research · doi:10.1016/j.trsl.2019.12.005 · Cited by 34
Remote solid cancers rewire hepatic nitrogen metabolism via host nicotinamide-N-methyltransferase
Mizuno, R., Hojo, H., Takahashi, M., Kashio, S., Enya, S., Nakao, M., Konishi, R., Yoda, M., Harata, A., Hamanishi, J., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30926-z · Cited by 34
Bench-to-Bedside Studies of Arginine Deprivation in Cancer
Field, G., Pavlyk, I., & Szlosarek, P. W. (2023) · Molecules · doi:10.3390/molecules28052150 · Cited by 34
Yang, C., Pataskar, A., Feng, X., Navarro, J. M., Paniagua, I., Jacobs, J. J. L., Zaal, E. A., Berkers, C. R., Bleijerveld, O. B., & Agami, R. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.04.012 · Cited by 33
The metabolomic signature of hematologic malignancies
Allegra, A., Innao, V., Gerace, D. G., Bianco, O., & Musolino, C. (2016) · Leukemia Research · doi:10.1016/j.leukres.2016.08.002 · Cited by 32
Badeaux, M. D., Rolig, A. S., Agnello, G., Enzler, D., Kasiewicz, M. J., Priddy, L., Wiggins, J. F., Muir, A., Sullivan, M. R., Cleef, J. V., et al. (2021) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-20-0317 · Cited by 35
Thongkum, A., Wu, C., Li, Y.-Y., Wangpaichitr, M., Navasumrit, P., Parnlob, V., Sricharunrat, T., Bhudhisawasdi, V., Ruchirawat, M., & Savaraj, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061175 · Cited by 33
Targeted Arginine Metabolism Therapy: A Dilemma in Glioma Treatment
Hou, X., Chen, S., Zhang, P., Guo, D., & Wang, B. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.938847 · Cited by 34
Fu, Y., Liu, S., Rodrigues, R. M., Han, Y., Guo, C., Zhu, Z., He, Y., Mackowiak, B., Feng, D., Gao, B., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71134 · Cited by 31
Do, L. K., Lee, H. M., Ha, Y., Lee, C., & Kim, J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115529 · Cited by 38
Amino acid metabolism in breast cancer: pathogenic drivers and therapeutic opportunities
Liu, Y., Zong, X., Altea‐Manzano, P., & Fu, J. (2025) · Protein & Cell · doi:10.1093/procel/pwaf011 · Cited by 32
Protein interactome of the deamidase phosphoribosylformylglycinamidine synthetase (PFAS) by LC-MS/MS
Ai, L., Disoma, C., Zhou, Y., Chen, Z., Zhang, L., Shen, Y., Zhou, M., Du, A., Zheng, R., Li, S., et al. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.04.039 · Cited by 30
Arginine depriving enzymes: applications as emerging therapeutics in cancer treatment
Kumari, N., & Bansal, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04335-w · Cited by 30
Huang, Y., Lien, Y., Chen, J.-H., Lin, E., & Huang, C.-Y. (2020) · Biochimie · doi:10.1016/j.biochi.2020.03.005 · Cited by 29
Chan, P. Y., Phillips, M. M., Ellis, S. M., Johnston, A. L., Feng, X., Arora, A., Hay, G. R., Cohen, V. M. L., Sagoo, M. S., Bomalaski, J. S., et al. (2022) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.13042 · Cited by 29
Metabolic reprogramming in nasopharyngeal carcinoma: Mechanisms and therapeutic opportunities
Liu, Q., Bode, A. M., Chen, X., & Luo, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.189023 · Cited by 28
Luo, W., Zou, Z., Nie, Y., Luo, J., Ming, Z., Hu, X., Luo, T., Ouyang, M., Mingquan, L., Tang, H., et al. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06672-z · Cited by 32
Szlosarek, P. W., Phillips, M. M., Pavlyk, I., Steele, J. P. C., Shamash, J., Spicer, J. F., Kumar, S. S., Pacey, S., Feng, X., Johnston, A. L., et al. (2020) · JTO Clinical and Research Reports · doi:10.1016/j.jtocrr.2020.100093 · Cited by 28
Meng, X., Peng, J., Xie, X., Yu, F., Wang, W., Pan, Q., Jin, H., Huang, X., Yu, H., Li, S., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02413-8 · Cited by 28
The mitochondrial carrier Citrin plays a role in regulating cellular energy during carcinogenesis
Rabinovich, S., Silberman, A., Adler, L. N., Agron, S., Levin‐Zaidman, S., Bahat, A., Porat, Z., Ben‐Zeev, E., Geva, I., Itkin, M., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0976-2 · Cited by 30
Self-citationWang, X., Yin, Y., Qian, W., Peng, C., Shen, S., Wang, T., & Zhao, S. (2022) · The FASEB Journal · doi:10.1096/fj.202101993rr · Cited by 27
Li, T., Zhu, Y., Cheng, F., Lu, C., Jung, J. U., & Gao, S. (2018) · Journal of Virology · doi:10.1128/jvi.01599-18 · Cited by 26
Reprogramming of urea cycle in cancer: Mechanism, regulation and prospective therapeutic scopes
Ghosh, N., Mahalanobish, S., & Sil, P. C. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116326 · Cited by 26
AspSnFR: A genetically encoded biosensor for real-time monitoring of aspartate in live cells
Hellweg, L., Pfeifer, M., Tarnawski, M., Thing-Teoh, S., Chang, L., Bergner, A., Kress, J., Hiblot, J., Wiedmer, T., Superti‐Furga, G., et al. (2024) · Cell chemical biology · doi:10.1016/j.chembiol.2024.05.002 · Cited by 24
Dai, Z., Xu, L., Xu, L., Liao, K., Deng, S., Chen, Q., Wang, Q., Wang, Q., Gao, S., Li, B., et al. (2019) · Cell Communication and Signaling · doi:10.1186/s12964-019-0439-y · Cited by 26
Carlisle, S. M., Trainor, P. J., Hong, K. U., Doll, M. A., & Hein, D. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-66863-4 · Cited by 24
Targeting Nutrient Dependency in Cancer Treatment
Fan, K., Liu, Z., Gao, M., Tu, K., Xu, Q., & Zhang, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.820173 · Cited by 26
Fujigaki, S., Nishiumi, S., Kobayashi, T., Suzuki, M., Iemoto, T., Kojima, T., Ito, Y., Daiko, H., Kato, K., 広和, 庄., et al. (2018) · Biomarkers in Medicine · doi:10.2217/bmm-2017-0449 · Cited by 24
Crystal structure of dihydropyrimidinase in complex with anticancer drug 5-fluorouracil
Huang, Y., Ning, Z.-J., & Huang, C.-Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.08.153 · Cited by 24
Tissue Nutrient Environments and Their Effect on Regulatory T Cell Biology
Blagih, J., Hennequart, M., & Zani, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637960 · Cited by 25
Snail enhances arginine synthesis by inhibiting ubiquitination-mediated degradation of ASS1
Jia, H., Yang, Y., Li, M., Chu, Y., Song, H., Zhang, J., Zhang, D., Zhang, Q., Xu, Y., Wang, J., et al. (2021) · EMBO Reports · doi:10.15252/embr.202051780 · Cited by 23
Pharmacologic approaches to amino acid depletion for cancer therapy
Wilder, C. S., Chen, Z., & DiGiovanni, J. (2021) · Molecular Carcinogenesis · doi:10.1002/mc.23349 · Cited by 23
Dietary Manipulation of Amino Acids for Cancer Therapy
Jiménez‐Alonso, J. J., & López‐Lázaro, M. (2023) · Nutrients · doi:10.3390/nu15132879 · Cited by 26
Ding, D., Blee, A. M., Zhang, J., Pan, Y., Becker, N. A., Maher, L. J., Jiménez, R. E., Wang, L., & Huang, H. (2023) · Nature Communications · doi:10.1038/s41467-023-40352-4 · Cited by 24
Huang, C.-Y. (2020) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2020.05.002 · Cited by 23
Fang, X. J., Yuan, M., Dai, J., Lin, Q., Lin, Y., Wang, W., Jiang, Y., Wang, H., Zhao, F., Wu, J., et al. (2022) · Nano Research · doi:10.1007/s12274-022-4237-2 · Cited by 21
Intratumoral lipid metabolic reprogramming as a pro-tumoral regulator in the tumor milieu
Wang, R., Hu, Q., Wu, Y., Guan, N., Han, X., & Guan, X. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188962 · Cited by 22
Genetics of enzymatic dysfunctions in metabolic disorders and cancer
Mahé, M., Rios-Fuller, T. J., Karolin, A., & Schneider, R. J. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1230934 · Cited by 23
Systems level profiling of arginine starvation reveals MYC and ERK adaptive metabolic reprogramming
Brashears, C. B., Barlin, M., Ehrhardt, W. R., Rathore, R., Schultze, M., Tzeng, S.-C., Tine, B. A. V., & Held, J. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-02899-8 · Cited by 21
Physiological impact of in vivo stable isotope tracing on cancer metabolism
Grima-Reyes, M., Martinez-Turtos, A., Abramovich, I., Gottlieb, E., Chiche, J., & Ricci, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101294 · Cited by 24
Grasping for aspartate in tumour metabolism
Fu, A., & Danial, N. N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0137-9 · Cited by 19
Wu, D., Yang, S., Yuan, C., Zhang, K., Tan, J., Guan, K., Zeng, H., & Huang, C. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.136828 · Cited by 21
Urea cycle dysregulation: a new frontier in cancer metabolism and immune evasion
Shou, Y., Liu, R., Xiong, H., Xu, K., Chen, X., Huang, L., Zhang, Y., Sheng, H., Zhang, H., & Lü, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02328-3 · Cited by 19
Arginine Expedites Erastin-Induced Ferroptosis through Fumarate
Guo, X., Guo, Y., Li, J., Liu, Q., & Wu, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914595 · Cited by 18
Givechian, K. B., Garner, C. P., Garbán, H., Rabizadeh, S., & Soon‐Shiong, P. (2018) · Oncotarget · doi:10.18632/oncotarget.25701 · Cited by 18
The role of orotic acid measurement in routine newborn screening for urea cycle disorders
Staretz‐Chacham, O., Daas, S., Ulanovsky, I., Blau, A., Rostami, N., Saraf‐Levy, T., Salah, N. A., Anikster, Y., Banne, E., Dar, D. E., et al. (2020) · Journal of Inherited Metabolic Disease · doi:10.1002/jimd.12331 · Cited by 18
Self-citationZhang, Y., Higgins, C. B., Tine, B. A. V., Bomalaski, J. S., & DeBosch, B. J. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100498 · Cited by 19
Artemether Alleviates Diabetic Kidney Disease by Modulating Amino Acid Metabolism
Rong, G., Weng, W., Huang, J., Chen, Y., Yu, X., Yuan, R., Gu, X., Wu, X., Cai, Y., Han, P., et al. (2022) · BioMed Research International · doi:10.1155/2022/7339611 · Cited by 17
Owusu-Ansah, M., Guptan, N., Alindogan, D., Morizono, M., & Caldovic, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076754 · Cited by 18
Rogers, L. C., & Tine, B. A. V. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.49 · Cited by 17
Szlosarek, P. W., Wimalasingham, A. G., Phillips, M. M., Hall, P. E., Chan, P. Y., Conibear, J., Lim, L., Rashid, S., Steele, J. P. C., Wells, P., et al. (2021) · Cancer Medicine · doi:10.1002/cam4.4196 · Cited by 17
Arginine Deprivation in SCLC: Mechanisms and Perspectives for Therapy
Carpentier, J., Pavlyk, I., Mukherjee, U., Hall, P. E., & Szlosarek, P. W. (2022) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s335117 · Cited by 16
Metadata
- Authors
- Rabinovich, S., Adler, L., Yizhak, K., Sarver, A., Silberman, A., Agron, S., Stettner, N., Sun, Q., Brandis, A., Helbling, D., Korman, S., Itzkovitz, S., Dimmock, D., Ulitsky, I., Nagamani, S. C. S., Ruppin, E., & Erez, A.
- Affiliations
- Weizmann Institute of Science (IL)
- Tel Aviv University (IL)
- Baylor College of Medicine (US)
- Medical College of Wisconsin (US)
- Hadassah Medical Center (IL)
- Corresponding author
- Erez, Ayelet
- ORCID
- Venue
- Nature
- Published
- 2015-11
- Volume
- 527
- Issue
- 7578
- Pages
- 379-383
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4655447
- OpenAlex
- W2129920232
- Cited by
- 382
- References
- 26
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 34 · 2023: 38 · 2022: 48 · 2021: 58 · 2020: 30 · 2019: 32 · 2018: 30 · 2017: 19 · 2016: 15 · 2015: 1
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Doris Duke Charitable Foundation (2013095)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD083092)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Keywords
- argininosuccinate synthetase, aspartate transcarbamylase, dihydroorotase, pyrimidine synthesis, urea cycle, citrullinemia, citrin, aspartic acid, mTOR signaling, S6K1, tumor cell proliferation, metabolic reprogramming, citrulline
- MeSH terms
- Animals, Argininosuccinate Synthase, Aspartate Carbamoyltransferase, Aspartic Acid, Calcium-Binding Proteins, Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing), Cytosol, Dihydroorotase, Enzyme Activation, Humans, Male, Neoplasms, Phosphorylation, Pyrimidines, Down-Regulation, Mice, SCID, Citrullinemia, Organic Anion Transporters, Cell Line, Tumor, Cell Proliferation, Mice, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
